The need for ‘onco-nephrology’ is increasing in hematopoietic stem cell transplantation

Ando, Minoru

doi:10.1038/bmt.2016.68

Cited by 1 publication

(1 citation statement)

References 16 publications

(17 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Therefore, hematologists evaluating SCT should be fully aware of the development of these kidney diseases after SCT. Furthermore, SCT requires cooperation by onco-nephrologists, who are experienced in the treatment of hematological malignancies and SCT procedures as well as facilitating the best treatment for renal disease in SCT recipients ( 17 , 18 ).…”

Section: Introductionmentioning

confidence: 99%

An Overview of Kidney Disease Following Hematopoietic Cell Transplantation

Ando

2018

Intern. Med.

View full text Add to dashboard Cite

Hematopoietic stem cell transplantation (SCT) recipients are exposed to a large amount of anti-cancer drugs, immunosuppressors, and irradiation during the peri-SCT period. Thus, they have to overcome serious adverse events related to unavoidable but toxic procedures, including organ disorders. In particular, acute kidney injury (AKI) is one of the most critical complications, because it influences the mortality of patients. A few patients who survive AKI may develop nephrotic syndrome, and precedent AKI is also closely associated with chronic and progressive loss of the renal function in post-SCT patients. These kidney diseases place a heavy burden on SCT patients, both medically and economically. Therefore, hematologists who evaluate SCT should be fully aware of the development of these kidney diseases after SCT. We herein review the common course of kidney disease development following allogeneic SCT to provide healthcare professionals with practical information on renal disease in SCT patients.

show abstract

Section: Introductionmentioning

confidence: 99%

An Overview of Kidney Disease Following Hematopoietic Cell Transplantation

Ando

2018

Intern. Med.

View full text Add to dashboard Cite

show abstract

The need for ‘onco-nephrology’ is increasing in hematopoietic stem cell transplantation

Cited by 1 publication

References 16 publications

An Overview of Kidney Disease Following Hematopoietic Cell Transplantation

An Overview of Kidney Disease Following Hematopoietic Cell Transplantation

Contact Info

Product

Resources

About